DXCM

SELL

DexCom, Inc.

Healthcare · Rank #122 · Analyzed Oct 18, 2026

$86.04

Current Price

$37.92

Intrinsic Value

-55.9%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 55.9%

Fair Value Range

Low$5.62

Base (IV)$37.92

High$50.21

Entry Points

Conservative$3.93

Moderate$5.62

Aggressive$26.54

Quality & Moat Breakdown

Return on Equity38.5% → 1.0/1.0

Debt LevelD/E 53 → 0.5/1.0

Revenue QualityGrowth 16.6%, margin Δ-2.3% → 0.5/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins20.1% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.